Ametek 10-Qquarter ended 2026-09-30

Executive Summary

AMETEK sells precision instruments and electromechanical products to industrial, scientific, aerospace and defense customers, earning revenue from specialized equipment and components. It is expanding that portfolio through acquisitions, led by the $4.92B Indicor Instrumentation purchase, while using Operational Excellence to improve productivity. Q3 organic sales growth accelerated to 10%, orders outpaced sales, and operating margins improved despite acquisition costs. The opportunity is to combine stronger demand with Indicor’s specialized businesses; the investor test is whether integration and cash generation justify the substantially higher borrowing.

What's Happening in the Business

Indicor, acquired in August, changes AMETEK’s scale and financing requirements. Its businesses generate ≈$1.1B in annual sales and broaden AMETEK’s industrial and scientific instrumentation portfolio. Alongside LKC Technologies and First Aviation, the acquisitions extend AMETEK into ophthalmic diagnostics, aviation maintenance and proprietary components. The 2026 acquisitions had an immaterial effect on reported-period results, so their contribution remains largely ahead; acquisition growth this quarter also reflects earlier deals, including FARO.

Demand strengthened beyond acquisitions. Organic sales growth reached 10% in Q3 vs 8% over 9M, while organic orders grew 17%. Both operating groups participated, with Electromechanical Group growing faster and expanding its margin. This supports a broader demand recovery rather than growth dependent solely on purchased businesses.

Management attributes productivity improvements to Operational Excellence. Electronic Instruments Group’s reported margin was broadly flat because integration costs and acquired-business margins absorbed underlying improvement. Targeted pricing, supply-chain adjustments and localized production helped manage tariffs, which had no material effect on 9M results.

Key Financial Highlights

• Segment drivers: Electronic Instruments Group organic sales rose 9%; its 28.2% margin included $7.8M of Indicor integration costs. Electromechanical Group organic sales rose 13%, and its margin expanded to 27.0% from 25.4%. Corporate general and administrative costs outside the segments increased 14% to $31.8M.
• Orders and visibility: Q3 orders reached $2.65B, +35%, including 18 percentage points from acquisitions. Backlog reached $4.54B, +27% since year-end. It represents future revenue, not cash or profit; acquisition contributions mean the increase is not purely organic.
• Financing costs: Q3 interest expense rose 77% to $39.8M. The 9M total included $10.0M of terminated bridge-financing fees; acquisition transaction costs added $18.1M to other expense.
• Acquisition accounting: Goodwill reached $10.2B and other intangible assets $6.52B, leaving tangible common equity at $(5.04)B vs $(670)M at year-end. Expected annual amortization from 2026 acquisitions is ≈$133M for each of the next five years, creating a continuing earnings charge.
• Cash deployment: Acquisition spending was $5.35B vs capital expenditures of $90.7M. Cash generation supported the program but was far below the purchase outlay, explaining the borrowing increase.

Risk Assessment

• Acquisition execution and valuation: Indicor’s purchase accounting remains incomplete, and the enlarged goodwill and intangible balances expose earnings and equity to integration shortfalls or impairment.
• Financing exposure: The acquisition-funded debt increase includes variable-rate term loans maturing in three to five years; interest costs and refinancing needs make sustained cash generation more consequential, although AMETEK reported covenant compliance.
• Trade and supply disruption: Tariff changes, geopolitical uncertainty including the Iran conflict, and raw-material or supply-chain disruption could undermine the pricing and localized-production measures that protected results this period.

No risk-factor section was found in this 10-Q. A 10-Q does not have to restate the risk factors in the annual report. Full list: the company's 10-Ks on SEC.

What to Watch

• Demand conversion: Q3 organic orders grew faster than organic sales; subsequent filings should show whether orders convert into shipments or accumulate through delays and cancellations.
• Indicor integration: Its ≈$1.1B annual sales base should become visible in reported growth; sustained contribution would support the purchase, while persistent integration costs or impairment would weaken the case.
• Electromechanical profitability: The 27.0% segment margin tests whether productivity gains endure as acquisitions enter the business; sustained margins would validate the improvement, while reversal would challenge it.
• Debt reduction: Following the borrowing surge, watch whether operating cash flow funds repayment or whether further acquisitions keep debt and interest costs elevated.

Not present in this filing: Item 3, Quantitative and Qualitative Disclosures About Market Risk; Part II Item 1A, Risk Factors.